Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 34 DKK 0.29% Market Closed
Market Cap: 14.5B DKK

Intrinsic Value

The intrinsic value of one EMBLA stock under the Base Case scenario is 35.8 DKK. Compared to the current market price of 34 DKK, Embla Medical hf is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EMBLA Intrinsic Value
35.8 DKK
Undervaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare EMBLA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EMBLA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Embla Medical hf
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Embla Medical hf

Current Assets 419.3m
Cash & Short-Term Investments 93.2m
Receivables 126m
Other Current Assets 200.2m
Non-Current Assets 1.2B
Long-Term Investments 26.3m
PP&E 207.8m
Intangibles 886.6m
Other Non-Current Assets 48.7m
Efficiency

Free Cash Flow Analysis
Embla Medical hf

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Embla Medical hf

Revenue
857.8m USD
Cost of Revenue
-315.8m USD
Gross Profit
542m USD
Operating Expenses
-422.1m USD
Operating Income
120m USD
Other Expenses
-47.8m USD
Net Income
72.2m USD
Fundamental Scores

EMBLA Profitability Score
Profitability Due Diligence

Embla Medical hf's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
Operating Margin is Increasing
50/100
Profitability
Score

Embla Medical hf's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

EMBLA Solvency Score
Solvency Due Diligence

Embla Medical hf's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

Embla Medical hf's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EMBLA Price Targets Summary
Embla Medical hf

Wall Street analysts forecast EMBLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMBLA is 34.37 DKK with a low forecast of 26.26 DKK and a high forecast of 39.38 DKK.

Lowest
Price Target
26.26 DKK
23% Downside
Average
Price Target
34.37 DKK
1% Upside
Highest
Price Target
39.38 DKK
16% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EMBLA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EMBLA stock?

The intrinsic value of one EMBLA stock under the Base Case scenario is 35.8 DKK.

Is EMBLA stock undervalued or overvalued?

Compared to the current market price of 34 DKK, Embla Medical hf is Undervalued by 5%.

Back to Top